Credit: Unsplash/CC0 Public Domain
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy
New research has moved a step closer to harnessing viruses to fight bacterial infection, reducing the threat of antibiotic resistance.
A growing number of infections, including pneumonia, tuberculosis, gonorrhoea, and salmonellosis, are developing antibiotic resistance, which means they becoming harder to treat, resulting in higher death rates, longer hospital stays and higher costs.
Phage therapy is the concept of using viruses (known as phage) that are harmless to humans to kill bacteria. Phage therapy can be used in combination with antibiotics to cure infections more effectively, and reduce the opportunity for bacteria to develop antibiotic resistance. However, bacteria can also evolve resistance to phages.
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy. Researchers conducted laboratory experiments on Pseudomonas aeruginosa a bacterium which causes disease in immunocompromised and cystic fibrosis patients. They exposed the bacterium to eight types of antibiotics – and found differences in the mechanisms by which the bacteria evolve resistance to phages, which affect how harmful they are.
Viruses penetrate molecules on the cell surface to infect bacteria. Like the human immune system, bacteria have their own CRISPR defence system, made up of proteins that fight off infection. As in human immune responses, this means that the virus infects the bacteria, and is then killed. In the process, the bacteria’s CRISPR system learns to recognise and attack the virus in future.
However, the bacteria have a second defence option. They can also change their own cell surface to ward off infection, losing the receptor to which phages normally attach. This option comes with a cost to bacteria – the bacteria become less virulent, meaning they no longer cause disease, or the disease becomes less severe.
In the study, four of the eight antibiotics tested caused a dramatic increase in the levels of CRISPR-based immunity. These antibiotics are all bacteriostatic – they do not directly kill cells but act by slowing down cell growth.
Professor Edze Westra, of the University of Exeter, said; “Antibiotic resistance is a major public health issue, and we need to take swift and urgent action. Phage therapy could be an important part of the toolkit, in reducing antibiotic use, and in using them in combination to increase their efficiency. We found that by changing the type of antibiotics that are used in combination with phage, we can manipulate how bacteria evolve phage resistance, increasing the chances that treatment is effective. These effects should be considered during phage-antibiotic combination therapy, given their important consequences for pathogen virulence.”
Phage therapy was first used in 1919, when Parisian microbiologist Félix d’Hérelle gave a phage cocktail to a 12-year-old boy, apparently curing his severe dysentery. Yet despite early promise, research dried up in the 40s as the world began to adopt the quick medical fix of antibiotics.
Now, research is again gathering momentum as part of the solution to reduce antibiotic resistance. Although a promising alternative with some remarkable case studies of phage therapy working in individuals, one obstacle to wider use is that bacteria can rapidly evolve resistance to phages, via CRISPR-Cas immunity or via modification of their surface.
The researchers show that the effect of bacteriostatic antibiotics triggering CRISPR-Cas immunity results from slower phage replication inside the cell, which provides more time for the CRISPR-Cas system to acquire immunity and clear the phage infection. The research therefore identifies the speed of phage replication as a crucial factor controlling the possibility for CRISPR-Cas systems to defend against viruses.
Lead author Dr Tatiana Dimitiru, of the University of Exeter, said: This study provides fundamental insight into the constraints of CRISPR immune systems in the face of viruses. It was recently discovered that many CRISPR-Cas immune systems are associated to cell responses that make bacteria slow or stop growth upon phage infection, and we speculate that this may be important for cells to trigger an effective immune response.
Original Article: New research moves closer to harnessing viruses to fight bacteria and reduce antibiotic use
More from: University of Exeter
The Latest on: Combining antibiotics and phage therapy
- What You Should Eat During and After Antibioticson March 16, 2023 at 5:00 pm
Taking probiotics during and after a course of antibiotics may help support your digestion and reduce side effects including diarrhea. Eating high fiber and prebiotic foods may also help.
- Introducing Yesterday's Phage Therapy in Today's Medicineon March 5, 2023 at 4:00 pm
The authors thank the FWO Vlaanderen ('PhageBiotics' research community grant WO.022.09) for its support. J-P Pirnay and M Merabishvili were supported by grant MED 12 of the Royal High Institute ...
- Antibiotics Combination Proves Effective for Severe Scrub Typhuson March 3, 2023 at 5:47 am
As Orientia tsutsugamushi is a bacterium which multiplies and survives inside host cells, it is important that the antibiotic ... and multiplication. As combination therapy quickly controlled ...
- Phage Therapy Market Size 2023 - 2030 Global Average Price, Deployment, Development, Growth Factor, Regional outlook, Application.on March 2, 2023 at 7:29 am
The growth of the Phage Therapy market is expected to increase due to the rising prevalence of antibiotic-resistant infections and the increasing demand for alternative therapies. Additionally ...
- Combination Therapy for Follicular Lymphomaon March 1, 2023 at 4:01 pm
If your disease seems stable and you feel good, you can put off radiation or drug therapy. After you watch and wait for a while, you may need some type of combination therapy. Combination chemothe ...
- Antibiotics in Fixed Combinationon March 1, 2023 at 4:01 pm
It was this combination that was supposed to epitomize the "New Antibiotic Era" or the "Third ... their use both in hospitals as initial therapy before an etiologic diagnosis is reached and ...
- Introducing Yesterday's Phage Therapy in Today's Medicineon February 21, 2023 at 4:00 pm
Could (bacterio)phages, the viruses of bacteria, help fight antibiotic-resistant bacteria? [16–18] A virus is a natural biological entity, consisting in essence of a molecular assemblage of ...
- Phage Therapy Market Forecast Report 2023 Expected to Project a Notable CAGR of 10.91% in 2028 with USD 176.75 million in 2023 |117 Pages Reporton February 9, 2023 at 1:48 am
Phage Therapy Market research report offers ... Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material ...
- What's stopping antibiotic de-escalation therapy?on February 1, 2023 at 4:32 am
Everyone seems to agree that antibiotic de-escalation therapy seems to make sense. The big question is therefore why aren't we doing it? Antibiotic de-escalation therapy is the practice of using ...
- Can You Drink on Antibiotics? The Truth About Mixing Antibiotics and Alcoholon October 27, 2022 at 10:45 am
In fact, drinking alcohol while taking a course of antibiotics can be a dangerous combination. “Without antibiotics, it would be incredibly difficult to fight harmful infections,” says Dr ...
via Bing News
The Latest on: Combining antibiotics and phage therapy
[google_news title=”” keyword=”combining antibiotics and phage therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News